Meiji Yasuda Asset Management CO Ltd. Jazz Pharmaceuticals PLC Transaction History

Meiji Yasuda Asset Management CO Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $280,833 - $323,693	2,438 New	2,438 $293,000
Q4 2019 Feb 13, 2020	SELL	$117.65 - $153.73 $211,770 - $276,714	-1,800 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$125.18 - $143.24 $225,324 - $257,832	1,800 New	1,800 $231,000
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $472,821 - $544,111	-3,766 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $190,754 - $223,859	1,566 Added 71.18%	3,766 $538,000
Q4 2018 Feb 12, 2019	SELL	$115.94 - $166.74 $185,504 - $266,784	-1,600 Reduced 42.11%	2,200 $273,000
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $32,202 - $36,114	200 Added 5.56%	3,800 $639,000
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $29,266 - $36,636	-200 Reduced 5.26%	3,600 $620,000
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $271,180 - $314,320	2,000 Added 111.11%	3,800 $574,000
Q4 2017 Feb 13, 2018	SELL	$131.06 - $150.39 $183,484 - $210,545	-1,400 Reduced 43.75%	1,800 $242,000
Q3 2017 Nov 08, 2017	BUY	$142.62 - $155.6 $456,384 - $497,920	3,200	3,200 $468,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.